NOTE 6 - CAPITAL STOCK (Details) - USD ($)	Apr. 02, 2019	Mar. 31, 2018	Mar. 31, 2015	Mar. 30, 2015	Aug. 01, 2014	Dec. 06, 2011	Nov. 22, 2011	Jun. 30, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2014
Common Stock, Shares Authorized								100,000,000	100,000,000
Common Stock, Par or Stated Value Per Share								$ 0.0001	$ 0.0001
Proceeds from issuance of restricted shares	$ 14,490
Stock Issued During Period, Shares, Restricted Stock Award, Gross	21,000
Common Stock, Shares, Issued								30,000,000	30,000,000	25,876,900	26,221,000
Common Stock, Shares, Outstanding								30,000,000	30,000,000	25,876,900	26,221,000
Convertible Notes Payable
Due to Related Parties, Current												$ 470,935
GS Pharmaceuticals, Inc. | Convertible Notes Payable
Debt Instrument, Face Amount													$ 330,000
Director
Stock Issued During Period, Shares, New Issues						1,200,000	25,000,000
Shares Issued, Price Per Share						$ 0.000833	$ 0.0008
Stock Issued During Period, Value, Issued for Services						$ 1,000	$ 20,000
Preferred Class A
Preferred Stock, Shares Authorized								20,000,000	20,000,000
Preferred Stock, Par or Stated Value Per Share								$ 0.0001	$ 0.0001
Preferred Stock, Shares Issued								10,000	10,000	10,000	10,000
Preferred Stock, Shares Outstanding								10,000		10,000	10,000
Series A Preferred Stock
Preferred Stock, Shares Authorized								10,000
Series A Preferred Stock | Redfield Holdings Ltd
Stock Issued During Period, Shares, New Issues				9,700	300
Shares Issued, Price Per Share					$ 1
Debt Conversion, Converted Instrument, Amount				$ 58,000	$ 300
Series B Preferred Stock
Redeemable Preferred Stock, Shares Issued								330,000	0	330,000	330,000
Redeemable Preferred Stock, Shares Outstanding								330,000	0	330,000	330,000
Series B Preferred Stock | GS Pharmaceuticals, Inc.
Debt Conversion, Converted Instrument, Shares Issued			330,000
Series C Preferred Stock
Redeemable Preferred Stock, Shares Issued								470,935	0	470,935	470,935
Redeemable Preferred Stock, Shares Outstanding								470,935	0	470,935	470,935
Series C Preferred Stock | Redfield Holdings Ltd
Debt Conversion, Converted Instrument, Shares Issued		470,935